在患有脱子低活性和BPO二次性功能障碍的患者中,HoLEP的有效性
Dengke Yang1, Qian Sun1, Weiyuan Li1
1Department of Urology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, No. 1111 Xianxia Rd, Shanghai, China.
World journal of urology
|September 6, 2024
概括
前列腺的霍尔激光核化 (HoLEP) 有效地治疗良性前列腺阻塞 (BPO) 带有体低活性 (DU) 和功能障碍. 患者在手术后恢复自发排泄,膀和功能得到改善.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 手术创新 在外科创新.
- 脏生理学 脏生理学
背景情况:
- 良性前列腺阻塞 (BPO) 可以导致体低活性 (DU) 和二次功能障碍.
- 与DU和功能障碍相关的BPO的管理带来了独特的挑战.
- 前列腺的霍尔激光取核 (HoLEP) 是一种微创手术选择.
研究的目的:
- 为了评估HoLEP的膀和功能结果.
- 评估BPO,DU和功能障碍患者的HoLEP疗效.
- 确定HoLEP对自发排泄和脏恢复的影响.
主要方法:
- 对31名BPO,DU和功能异常的患者进行前性研究.
- 患者接受了HoLEP,并在手术前和手术后1,3个月和6个月进行了评估.
- 关键参数包括国际前列腺症状评分 (IPSS),Qmax,功能 (血清肌素) 和骨前后直径 (RPAPD).
主要成果:
- 在6个月后观察到IPSS,QOL,Qmax,空气后残留量 (PVR),血清肌素和RPAPD的显著改善.
- 膀壁厚度呈现下降趋势,但没有显著变化.
- 没有发生重大不良事件;轻微的并发症被保守地管理,大多数患者恢复了自发排泄.
结论:
- HoLEP是一种有效的治疗BPO复杂的DU和功能障碍.
- 该程序可以保护和改善膀和功能.
- 在受影响的患者中,HoLEP促进了自发排泄的恢复.
相关概念视频
Heart Failure Drugs: Diuretics
352
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
352
Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa
145
The pH of urine, the drug's pKa, and the urine flow rate are vital parameters for drug reabsorption and excretion. Urinary pH varies between 4.6 and 8.0 and is influenced by diet, drug intake, and the patient's pathophysiology. It affects a drug's ionization state and reabsorption. For instance, carbohydrate-rich food produces alkaline urine promoting drug excretion, while proteins and certain medications like ascorbic acid lead to acidic urine enhancing reabsorption.
The pKa of a...
The pKa of a...
145
Antihypertensive Drugs: Potassium-Sparing Diuretics
476
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
476
Parkinson's Disease: Treatment
239
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
239
Drugs for Treatment of Constipation-Predominant IBS
146
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
146
Drugs for Treatment of Diarrhea-Predominant IBS
153
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
153


